KH Feelux Co., Ltd
CIK: 0002068957
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIMN
Liminatus Pharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About KH Feelux Co., Ltd
KH Feelux Co., Ltd (SEC CIK 0002068957) files insider reports with the SEC as 10% Owner of Liminatus Pharma, Inc. (LIMN).
Signal8 holds 1 ownership filing by KH Feelux Co., Ltd, a Form 3, filed on Jun 27, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on KH Feelux Co., Ltd's filings is in SEOUL, M5.
Other insiders filing for Liminatus Pharma, Inc. (LIMN)
- Valetudo Therapeutics LLC, 10% Owner
- Ewon Comfortech Co., Ltd., 10% Owner
- Iris Acquisition Holdings LLC, 10% Owner
- Lemons II Philip Wayne, Director
- Baek Richard JaiHwan, Director
- Lee Eun Sook, Director